Fig.3From: Changes in the BTK/NF-κB signaling pathway and related cytokines in different stages of neuromyelitis optica spectrum disordersProtein levels of CXCL2 and CXCL12 in the NMOSD group. Protein expression of CXCL2 and CXCL12 in the acute and remission groups (A–B). ★p < 0.001 vs. Vehicle group; ★p < 0.001 vs. remission groupBack to article page